Maxim Egorov

Mitochondria-targeted plastoquinone derivatives as tools to interrupt execution of the aging program. 2. Treatment of some ROS- and Age-related diseases (heart arrhythmia, heart infarctions, kidney ischemia, and stroke)

L. E. Bakeeva, Maxim Egorov, V. I. Kapelko et al. · Biochemistry (Moscow) · 2008 · 173 citations

Effects of the mitochondria-targeted antioxidant SkQ1 on lifespan of rodents

Vladimir N. Anisimov, Maxim Egorov, M. S. Krasilshchikova et al. · Aging · 2011 · 118 citations · Full text

Expression of proton-pumping nicotinamide nucleotide transhydrogenase in mouse, human brain and C. elegans

Eva Lagberg Arkblad, Maxim Egorov, M. I. Shakhparonov et al. · Comparative Biochemistry and Physiology Part B Biochemistry and Molecular Biology · 2002 · 46 citations

Molecular Neuroscience, Cellular Enzymology, Biochemistry +9

Ouabain‐sensitive H,K‐ATPase: tissue‐specific expression of the mammalian genes encoding the catalytic α subunit¹

Nikolay B. Pestov, Ludmila G. Romanova, Tatyana V. Korneenko et al. · FEBS Letters · 1998 · 43 citations · Full text

Novel mitochondria-targeted antioxidants, “Skulachev-Ion” derivatives, accelerate dermal wound healing in animals

I. A. Demianenko, T. V. Vasilieva, L. V. Domnina et al. · Biochemistry (Moscow) · 2010 · 34 citations